Life Technologies Corporation announced it plans to compete for the $10 million X PRIZE by being the first to rapidly and accurately sequence 100 whole human genomes at $1,000 a pop.
Ion Torrent, the next-generation sequencing (NGS) platform from Life Technologies, is the first official entrant in the Archon Genomics X PRIZE competition, presented by Express Scripts, which is intended to catalyze the development of a clinical grade $1,000 genome technology.
The Archon Genomics X PRIZE consists of a challenge to sequence 100 complete human genomes of people who are over 100 years old in one month for $100 or less per genome. The contest was announced in 2006, at a time when it would have cost $100 million and taken 33 years to meet this challenge. Initially, the goals were 100 miscellaneous genomes in just ten days for $10,000 or less, but in October 2011 these were changed to the current rules allowing for a bit more time.
Life Technologies Inc. has entered the first team in the $10 million Archon Genomics X Prize, the X Prize Foundation said Monday.
Life Technologies of Carlsbad has become the first company to enter the Archon Genomics X-Prize, a competition meant to produce the first machines and software that can sequence 100 entire human genomes for $1,000 or less. The winner gets $10 million in prize money.
Dorothy Delow certainly hasn't let age slow her down, venturing to Mongolia at age 97 to compete internationally in the World Veterans Games at table tennis, Natasha Johnson of the Australian Broadcasting Corporation reports.
If you’re a centenarian, or know one, they want to hear from you. The X Prize Foundation says their mission is simple — benefit humanity. Philanthropists and companies donate funds. The foundation puts on competitions with cash incentives. Five companies from around the world will study the DNA make-up of 100 centenarians.
The study is part of a competition called the Archon Genomics X PRIZE. The competition, presented by Medco Health Solutions, will present teams with the task of ordering 100 sets of DNA samples from centenarian donors with the goal of unlocking the secret to a longer life and developing more personalized medical care.
The Archon Genomics X Prize competition, which starts on January 3, is offering $US10 million to teams of scientists that analyse the genomes of 100 centenarians.
A hundred centenarians are being chosen worldwide to voluntarily contribute their DNA to the Archon Genomics X PRIZE competition, presented by Medco, a health care and research company based in New Jersey. It is a competition of world-class teams from genotyping companies that will compete to quickly, accurately and affordably sequence the genomes of the 100 centenarians.